Evidence map›Paper›PMID 42872485›Full record

ArticleCanadian journal of gastroenterology & hepatology2026

Symptom Network Analysis in Patients With Primary Sclerosing Cholangitis.

Melinda Wang, Amy M Shui, Joanne Hatchett, Stephen J Rossi, Ruth-Anne Pai, Rachel Gomel, Mary Pressley Vyas, Sarah Curup Callif, Ricky Safer, Jessica Rubin and 4 more

Abstract read
In one paragraph

Article in Canadian journal of gastroenterology & hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Melinda WangDivision of Gastroenterology and Hepatology, University of California, San Francisco, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0002-1305-8362
Amy M ShuiDepartment of Epidemiology and Biostatistics, University of California, San Francisco, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0002-8243-6910
Joanne HatchettPSC Partners Seeking a Cure, Greenwood Village, Colorado, USA.ORCID https://orcid.org/0009-0002-4326-8720
Stephen J RossiPSC Partners Seeking a Cure, Greenwood Village, Colorado, USA.ORCID https://orcid.org/0009-0001-7037-7079
Ruth-Anne PaiPSC Partners Seeking a Cure, Greenwood Village, Colorado, USA.
Rachel GomelPSC Partners Seeking a Cure, Greenwood Village, Colorado, USA.ORCID https://orcid.org/0009-0007-5111-4568
Mary Pressley VyasPSC Partners Seeking a Cure Canada, Toronto, Ontario, Canada.ORCID https://orcid.org/0009-0009-4673-0088
Sarah Curup CallifPSC Partners Seeking a Cure, Greenwood Village, Colorado, USA.ORCID https://orcid.org/0009-0002-8947-1767
Ricky SaferPSC Partners Seeking a Cure, Greenwood Village, Colorado, USA.
Jessica RubinDivision of Gastroenterology and Hepatology, University of California, San Francisco, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0003-2105-1256
Christopher BowlusUniversity of California Davis Health, Sacramento, California, USA, ucdavis.edu.ORCID https://orcid.org/0000-0002-3906-6811
Donna M EvonDivision of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA, unc.edu.ORCID https://orcid.org/0000-0002-1414-1846
Jennifer C LaiDivision of Gastroenterology and Hepatology, University of California, San Francisco, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0003-2092-6380
Michael LiDivision of Gastroenterology and Hepatology, University of California, San Francisco, California, USA, berkeley.edu.

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Y. Chen · 1986 to 2026
$30.7M
NRSA Hepatology Training GrantT32DK060414 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mandana Khalili, JACQUELYN J. MAHER · 2002 to 2026
$6.8M
Liver Center, University of California, San Francisco P30DK026743NIDDK NIH HHS P30 DK026743NIDDK NIH HHS T32 DK060414NIH HHS T32DK060414PSC Partners Young Investigator Award
6 · The paper itself

Abstract

introductionPatients with primary sclerosing cholangitis (PSC) experience numerous symptoms that impact quality of life. We sought to identify PSC-specific symptom clusters and relationships between symptoms to better understand the lived experience of PSC patients.

methodsPresence and severity of 16 symptoms were identified from the international "Our Voices" survey collected by PSC Partners Seeking A Cure in 2020. LASSO-regularized partial correlation network analysis was performed using Spearman correlations. The primary analysis utilized symptoms reported within the past 6 months of survey completion, with subgroup analyses conducted on patients with and without inflammatory bowel disease (IBD). Expected influence was computed to quantify the importance of each measure within networks. The Spinglass algorithm was employed to identify communities within networks.

resultsAmong 970 total participants, 54% were women, and 70% had IBD. Four dominant communities were identified across networks, including global symptoms, psychological symptoms, gastrointestinal symptoms, and cholestatic-related symptoms. Of the 16 symptoms included in network analyses, fatigue and weakness had the most positive influence across multiple networks and across different communities within each network.

conclusionsThe complex relationship between co-occurring symptoms in PSC organizes into four dominant symptom clusters. FTG and WEA emerged as strongly influential symptoms that consistently were associated with other symptoms. Our analyses emphasize the complex, co-occurring nature of PSC symptoms, identify highly influential symptoms, and highlight the need to develop patient-reported outcome symptom measures to assess changes in these key symptoms in clinical trials and clinical practice.

Indexed as

Cholangitis, SclerosingQuality of LifeAdultFatigueFemaleHumansInflammatory Bowel DiseasesMaleMiddle AgedSeverity of Illness IndexSurveys and QuestionnairesSymptom Burdenclusterfatiguenodesurveyweakness

Identifiers

PMID42872485
PMCPMC13662822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.